Brief: BioArctic Says Leqembi To Be Launched In Japan For Alzheimer's Disease On December 20
13/12/2023 02:07
Dec 12 (Reuters) - BioArctic AB BIOAb.ST :
* LEQEMBI® TO BE LAUNCHED IN JAPAN FOR ALZHEIMER'S DISEASE
ON
DECEMBER 20
Source text for Eikon: ID:nWkrc6sRzq
Further company coverage: BIOAb.ST
((Reuters.Briefs@thomsonreuters.com;))
Recent news on BioArctic AB (publ)
See all newsBrief: BioArctic Gets Leqembi Pen Subcutaneous Formulation Approval In Japan
Brief: BioArctic Says Leqembi Subcutaneous Formulation Approved For Initiation Treatment In China
Brief: BioArctic Says Canada's Drug Agency Issues Final Positive Recommendation Supporting Public Reimbursement Of Leqembi
Sweden's BioArctic Q2 revenue falls despite higher Leqembi royalties
Brief: BioArctic Q2 Net Sales Down At SEK 247.5 Mln